Induced Pluripotent Stem Cells: Production and Utility in Regenerative Medicine
Add to your list(s)
Download to your calendar using vCal
If you have a question about this talk, please contact Dr Shara Cohen.
The production of iPS cells from dermal fibroblasts has generated intense interest in the utility of such cells for research purposes and clinical applications. iPS cell production currently requires the use of transcription factor gene delivery to reprogramme cells into iPS cells. Hence, both gene delivery technology and iPS cell characterization and subsequent cell differentiation are critical aspects of iPS
cell biology. This meeting will address both issues
Website: www.regonline.co.uk/stemcell2011
This talk is part of the Euroscicon series.
This talk is included in these lists:
Note that ex-directory lists are not shown.
|